Cargando…

miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update

Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males between the ages of 20 and 40. Today, their surgical resection and chemotherapy are the treatments of first choice, even if sometimes this is not enough to save the lives of patients with TGCT. As seen...

Descripción completa

Detalles Bibliográficos
Autores principales: De Martino, Marco, Chieffi, Paolo, Esposito, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866514/
https://www.ncbi.nlm.nih.gov/pubmed/33573132
http://dx.doi.org/10.3390/ijms22031380
_version_ 1783648092833185792
author De Martino, Marco
Chieffi, Paolo
Esposito, Francesco
author_facet De Martino, Marco
Chieffi, Paolo
Esposito, Francesco
author_sort De Martino, Marco
collection PubMed
description Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males between the ages of 20 and 40. Today, their surgical resection and chemotherapy are the treatments of first choice, even if sometimes this is not enough to save the lives of patients with TGCT. As seen for several tumors, the deregulation of microRNAs (miRNAs) is also a key feature in TGCTs. miRNAs are small molecules of RNA with biological activity that are released into biological fluids by testicular cancer cells. Their presence, therefore, can be detected and monitored by considering miRNAs as diagnostic and prognostic markers for TGCTs. The purpose of this review is to collect all the studies executed on miRNAs that have a potential role as biomarkers for testicular tumors.
format Online
Article
Text
id pubmed-7866514
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78665142021-02-07 miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update De Martino, Marco Chieffi, Paolo Esposito, Francesco Int J Mol Sci Review Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males between the ages of 20 and 40. Today, their surgical resection and chemotherapy are the treatments of first choice, even if sometimes this is not enough to save the lives of patients with TGCT. As seen for several tumors, the deregulation of microRNAs (miRNAs) is also a key feature in TGCTs. miRNAs are small molecules of RNA with biological activity that are released into biological fluids by testicular cancer cells. Their presence, therefore, can be detected and monitored by considering miRNAs as diagnostic and prognostic markers for TGCTs. The purpose of this review is to collect all the studies executed on miRNAs that have a potential role as biomarkers for testicular tumors. MDPI 2021-01-30 /pmc/articles/PMC7866514/ /pubmed/33573132 http://dx.doi.org/10.3390/ijms22031380 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
De Martino, Marco
Chieffi, Paolo
Esposito, Francesco
miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
title miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
title_full miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
title_fullStr miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
title_full_unstemmed miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
title_short miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
title_sort mirnas and biomarkers in testicular germ cell tumors: an update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866514/
https://www.ncbi.nlm.nih.gov/pubmed/33573132
http://dx.doi.org/10.3390/ijms22031380
work_keys_str_mv AT demartinomarco mirnasandbiomarkersintesticulargermcelltumorsanupdate
AT chieffipaolo mirnasandbiomarkersintesticulargermcelltumorsanupdate
AT espositofrancesco mirnasandbiomarkersintesticulargermcelltumorsanupdate